FDA News

Software bug led to FDA recall of Accu-Chek Connect Diabetes Management App

The FDA recently announced a recall of Roche Diabetes Care Inc.’s Accu-Chek Connect Diabetes Management App due to a software bug in the Bolus Advisor feature, according to a press release.

The recall warns that certain iOS and Android App versions contain the program bug: When the OS region of the phone setting is changed, the unit of measure may also unexpectedly change, causing users to incorrectly enter numerical values for carbohydrate used for bolus advice and the app to not transfer the blood glucose result.

Users of the app are advised to clear all data from the Accu-Chek blood glucose meter before pairing with the Accu-Chek Connect app for the first time.

Full directions for clearing data from the Accu-Chek blood glucose meter can be found here.

The FDA recently announced a recall of Roche Diabetes Care Inc.’s Accu-Chek Connect Diabetes Management App due to a software bug in the Bolus Advisor feature, according to a press release.

The recall warns that certain iOS and Android App versions contain the program bug: When the OS region of the phone setting is changed, the unit of measure may also unexpectedly change, causing users to incorrectly enter numerical values for carbohydrate used for bolus advice and the app to not transfer the blood glucose result.

Users of the app are advised to clear all data from the Accu-Chek blood glucose meter before pairing with the Accu-Chek Connect app for the first time.

Full directions for clearing data from the Accu-Chek blood glucose meter can be found here.